Mostrando 10 resultados de: 13
Filtros aplicados
Subtipo de publicación
Article(13)
Publisher
The Lancet(6)
Gastroenterology(2)
Canadian Journal of Cardiology(1)
European Heart Journal - Cardiovascular Pharmacotherapy(1)
New England Journal of Medicine(1)
Área temáticas
Medicina y salud(7)
Farmacología y terapéutica(5)
Fisiología humana(3)
Salud y seguridad personal(3)
Cirugía y especialidades médicas afines(2)
Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study
ArticleAbstract: Background The relation between dietary nutrients and cardiovascular disease risk markers in many rePalabras claves:Autores:Agapay D., Aliberti A., Anand S.S., Aoucheva N., Arshad A., Avezum A.J., Azad A.K., Bangdiwala S.I., Casaccia G., Casanova A., Chen H., Cherry H.M., Chifamba J., Chin S.L., Chow C.K., Cuneo J.M., Dagenais G.R., Dehghan M., Devanath A., DIaz R., Dyal L., Elsheikh W., Gupta R., Hall K., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Iqbal R., Islam S., Iyengar Y., Joseph P.G., Kandy N., Kay I., Keneth J., Keys J., Khatib R., Kumar R., Kutty R., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Li W., Lindeman J., Linetsky B., Mackie P., Mannan A., McAlpine G., McQueen M.J., Mente A., Merchant A., Milazzo E., Mohammadifard N., Mohan V., Mushtaha M., Nasir N.M., Noorhassim I., Oguz A., Orlandini A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Puoane T., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Riggi M., Rimac J., Rosengren A., Seron P., Shahrook S., Shifaly F., Smyth A., Solano R., Swallow J., Swaminathan S., Teo K.K., Tongana T., Toscanelli S., Trottier M., Trottier S., Wang X., Wang Y., Wentzel-Viljoen E., Wielgosz A., Wong G.W.K., Yi S., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zatońska K., Zhang B., Zhang M.Fuentes:googlescopusAlcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: A prospective cohort study
ArticleAbstract: Summary Background Alcohol consumption is proposed to be the third most important modifiable risk faPalabras claves:Autores:Avezum A.J., Chifamba J., Dagenais G.R., DIaz R., Jian B., Kumar R., Lear S.A., Leong D.P., Mckee M., Mohan V., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rana P., Rangarajan S., Rosengren A., Schutte A.E., Seron P., Smyth A., Szuba A., Teo K.K., Wei L., Yang W., Yusuf S., Zhang X.Fuentes:googlescopusMortality and cardiovascular and respiratory morbidity in individuals with impaired FEV <inf>1</inf> (PURE): an international, community-based cohort study
ArticleAbstract: Background: The associations between the extent of forced expiratory volume in 1 s (FEV 1 ) impairmePalabras claves:Autores:Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., du Plessis J.L., Duong M.L., Gupta R., Igumbor E.U., Iqbal R., Islam S., Karsidag K., Killian K., Kumar R., Kurmi O.P., Lamelas P.M., Lanas F.T., Lear S.A., Leong D.P., Li W., Lu Y., Mohan V., Mony P.K., Nair S., Noorhassim I., O'Byrne P.M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wielgosz A., Yan R., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K., Zhi F.Fuentes:googlescopusPantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
ArticleAbstract: Background & Aims: Antiplatelets and anticoagulants are associated with increased upper gastrointestPalabras claves:drug, Heart Disease Prevention, Stomach, ThrombosisAutores:Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Commerford P.J., Connolly S.J., Cook-Bruns N., Dagenais G.R., Dans A.M., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Hori M., Kakkar A.K., Keltai M., Kim J.H., Lanas F.T., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Maggioni A.P., Metsarinne K.P., Moayyedi P., Muehlhofer E., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Shestakovska O., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Verhamme P.B., Vinereanu D., Widimsky P., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusModifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
ArticleAbstract: Background: Global estimates of the effect of common modifiable risk factors on cardiovascular diseaPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bo H., Brauer M., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Gupta R., Hystad P., Iqbal R., Islam S., Joseph P.G., Kaur M., Kelishadi R., Khatib R., Kruger L., Kutty V.R., Lanas F.T., Lear S.A., Leong D.P., Mckee M., Mente A., Mohan V., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wei L., Wielgosz A., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusLong-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
ArticleAbstract: Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheralPalabras claves:aspirin, Coronary artery disease, Peripheral artery disease, rivaroxabanAutores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bangdiwala S.I., Bhatt D.L., Bosch J.J., Branch K.R.H., Camillo Felix, Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.L., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Guzik T.J., Hori M., Ibrahim K.S., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Lopez-Jaramillo P., Maggioni A.P., Metsarinne K.P., Muehlhofer E., Neumann C., O’Donnell M., Parkhomenko A.N., Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Stoerk S., Tasto C., Tonkin A.M., Torp-Pedersen C., Tyrwitt J., Vanassche T., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yusuf S., Zhu J.Fuentes:scopusSafety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
ArticleAbstract: Background & Aims: Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. TPalabras claves:bacteria, CVD, Reflux, ThrombosisAutores:Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Bruns N.C., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Hart R.G., Hori M., Kakkar A.K., Keltai M., Kim J.H., Lanas F.T., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Maggioni A.P., Metsarinne K.P., Moayyedi P., Muehlhofer E., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Shestakovska O., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Verhamme P.B., Vinereanu D., Widimsky P., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusVariations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study
ArticleAbstract: Background: To our knowledge, no previous study has prospectively documented the incidence of commonPalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., DIaz R., Gupta R., Joseph P.G., Kaur M., Kazmi K., Kelishadi R., Khatib R., Lanas F.T., Leong D.P., Mohan V., Mony P.K., Noorhassim I., Oliveira G.B.F., Parambath S.R., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Temizhan A., Teo K.K., Vijayakumar K., Wei L., Wielgosz A., Yeates K.E., Yusuf S., Yusufali A.M., Zatońska K., Zhu J.Fuentes:googlescopusRationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
ArticleAbstract: Background Long-term aspirin prevents vascular events but is only modestly effective. Rivaroxaban alPalabras claves:Autores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bhatt D.L., Bosch J.J., Branch K.R.H., Bruns N.C., Chen E., Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.M., DIaz R., Eikelboom J.W., Ertl G., Felix Camilo, Fox K.A.A., Guzik T.J., Ha J.W., Hart R.G., Hori M., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Lanius V., Leong D.P., Lewis B.S., Liang Y., Liu L., Lonn E.M., Maggioni A.P., Metsarinne K.P., Misselwitz F., Moayyedi P., O’Donnell M., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Störk S., Tonkin A.M., Torp-Pedersen C., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yuan F., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusRivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
ArticleAbstract: Background: Patients with peripheral artery disease have an increased risk of cardiovascular morbidiPalabras claves:Autores:Aboyans V., ABRANTES J.A., AHUAD GUERRERO R.A., ALBISU DI GENNERO J.P., Alings M., ALVAREZ M., Anand S.S., Avezum A.J., Bangdiwala S.I., Barbieri M., BARTOLACCI I.P., Bhatt D.L., BORDONAVA A.P., Bosch J.J., Branch K.R.H., CACCAVO A., CARDONA M., CARTASEGNA L.U.I.S., Chacón C., Chen E., Commerford P.J., Connolly S.J., COSTABEL J.P., CUADRADO J., Cuneo C.A., DEBONNAIRE P., DIaz R., DRAN R.D., DUJARDIN K.A.R.L., ECTOR B.A.V.O., Eikelboom J.W., ELEGEERT I.V.A.N., FERRE PACORA F.A., Fox K.A.A., GARCIA DURAN R.O., GARRIDO M., Gomez Vilamajo O., GONZALEZ COLASO P.D.C., GRINFELD D., GUZMAN L.U.I.S., Hart R.G., HASBANI E., HERNANDES M., HOFFER E., HOMINAL M.A., HRABAR A., IBANEZ SAGGIA L.M., INDIO DO BRASIL C., Ingaramo A., Kakkar A.K., Keltai K., Leong D.P., LEROY J.E.A.N., Lewis B.S., LITVAK BRUNO M.R., LUCIARDI H.L., LUQUEZ H.U.G.O., MACIN S.M., MACKINNON I.J., MAFFEI L.E., Maggioni A.P., Maia L.N., MAJUL C.R., MANENTI E., Misselwitz F., Montaña O., NANI S., Novaretto L., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, PELAGAGGE M.J., Pogosova N., Precoma D.B., Reis G., ROSSI DOS SANTOS F., ROSSI P., Rydén L.E., SALA J., SARAIVA J.O.S.E., SARJANOVICH R.J., SCHIAVI L.B., SCHROE H., SCHYGIEL P.O., Störk S., VAN DE BORNE P., VAN DEN HEUVEL P.A.U.L., Vanassche T., Varigos J.D., VENSENTINI N., Verhamme P.B., VICO M., Vinereanu D., VITA N.A., VOGEL D., VRANCKX P., Widimsky P., Yan Duarte, Yusuf S., ZAIDMAN C., Zhu J., ZIMMERMANN S.L.Fuentes:scopus